1 research outputs found
Topical Formulation of Self-Assembled Antiviral Prodrug Nanomicelles for Targeted Retinal Delivery
Topical drug administration for back
of the eye delivery is extremely
challenging due to the presence of protection mechanisms and physiological
barriers. Self-assembled polymeric nanomicelles have emerged as promising
vehicles for drug delivery. Apart from serving as an inert nanocarrier
for therapeutic agents, polymeric nanomicelles are known to bypass
mononuclear phagocytic system (MPS) and efflux transporters thereby
improving drug bioavailability. In this investigation, a highly efficacious
biotinylated lipid prodrug of cyclic cidofovir (B–C12-cCDF)
was formulated within polymeric nanomicelles as a carrier for targeted
retinal delivery. Polymeric nanomicelles were prepared from polyoxyethylene
hydrogenated castor oil 40 (HCO-40) and octoxynol 40 (OC-40). In vitro
release studies revealed that B–C12-cCDF-loaded nanomicelles
released B–C12-cCDF at a faster rate in stimulated tear fluid
(STF) in comparison to PBST. MTT and LDH assays demonstrated negligible
cytotoxicity of B–C12-cCDF-loaded nanomicelles relative to
CDF and B–C12-cCDF in HRPE (human retinal pigment epithelial,
D407), HCE-T (human corneal epithelial), and CCL 20.2 (human conjunctival
epithelial) cells. Confocal laser scanning microscopy and flow cytometry
analyses indicated that B–C12-cCDF-loaded nanomicelles were
efficiently internalized into D407 and HCE-T cells in contrast to
CDF and B–C12-cCDF. Moreover, little B–C12-cCDF was
also observed in the nuclei after 24 h of incubation. Polymeric nanomicelles
carrying the transporter targeted prodrug did not produce any cytotoxic
effects and were internalized into the cells effectively. Permeability
experiments across HCE-T cells further confirmed significant transport
of prodrug loaded nanomicelles and their subsequent uptake into D407
cells. These findings indicate that HCO-40/OC-40 based polymeric nanomicelles
could become a promising topical delivery system for ocular administration
of antiviral agents